Clinical outcomes of laparoscopic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumor.

IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL
Hiroyuki Hanayama, Masanori Katagata, Takahiro Sato, Hiroshi Nakano, Takuro Matsumoto, Takeshi Tada, Yohei Watanabe, Suguru Hayase, Hirokazu Okayama, Tomoyuki Momma, Tsunetaka Kato, Minami Hashimoto, Jun Nakamura, Takuto Hikichi, Zenichiro Saze, Koji Kono
{"title":"Clinical outcomes of laparoscopic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumor.","authors":"Hiroyuki Hanayama,&nbsp;Masanori Katagata,&nbsp;Takahiro Sato,&nbsp;Hiroshi Nakano,&nbsp;Takuro Matsumoto,&nbsp;Takeshi Tada,&nbsp;Yohei Watanabe,&nbsp;Suguru Hayase,&nbsp;Hirokazu Okayama,&nbsp;Tomoyuki Momma,&nbsp;Tsunetaka Kato,&nbsp;Minami Hashimoto,&nbsp;Jun Nakamura,&nbsp;Takuto Hikichi,&nbsp;Zenichiro Saze,&nbsp;Koji Kono","doi":"10.5387/fms.2021-25","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Laparoscopic and endoscopic cooperative surgery (LECS) is a well-recognized surgical procedure for gastric gastrointestinal stromal tumor (GIST). In this report, we describe the clinical outcomes of LECS procedures for gastric GIST in our institution.</p><p><strong>Methods: </strong>We performed LECS procedures, including classical LECS, inverted LECS, closed LECS, and combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique (CLEAN-NET), in 40 gastric intraluminal and intramural type GIST patients, whose tumors were ≤ 50 mm in diameter, between September 2012 and December 2020. The patient background, surgical outcomes, postoperative morbidity and mortality, as well as the tumors' clinicopathological characteristics were analyzed retrospectively.</p><p><strong>Results: </strong>Pathological findings showed that most patients had a low or very low risk of tumor recurrence, while one patient had a high risk according to the modified-Fletcher's classification. The median length of postoperative hospital stay was 7 days. Only one patient had severe postoperative grade III complications according to the Clavien-Dindo (C-D) classification, after closed LECS, but was treated successfully with endoscopic hemostasis for postoperative hemorrhage. The remaining patients treated with LECS did not have severe complications. During the follow-up period (median, 31 months), all patients were disease-free, with no tumor recurrence or metastases.</p><p><strong>Conclusion: </strong>LECS is a safe surgical procedure for gastric intraluminal and intramural type GIST ≤ 50 mm in diameter, with good clinical outcomes.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":"68 3","pages":"169-174"},"PeriodicalIF":0.7000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/16/1c/2185-4610-68-169.PMC9840883.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fukushima Journal of Medical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5387/fms.2021-25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Laparoscopic and endoscopic cooperative surgery (LECS) is a well-recognized surgical procedure for gastric gastrointestinal stromal tumor (GIST). In this report, we describe the clinical outcomes of LECS procedures for gastric GIST in our institution.

Methods: We performed LECS procedures, including classical LECS, inverted LECS, closed LECS, and combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique (CLEAN-NET), in 40 gastric intraluminal and intramural type GIST patients, whose tumors were ≤ 50 mm in diameter, between September 2012 and December 2020. The patient background, surgical outcomes, postoperative morbidity and mortality, as well as the tumors' clinicopathological characteristics were analyzed retrospectively.

Results: Pathological findings showed that most patients had a low or very low risk of tumor recurrence, while one patient had a high risk according to the modified-Fletcher's classification. The median length of postoperative hospital stay was 7 days. Only one patient had severe postoperative grade III complications according to the Clavien-Dindo (C-D) classification, after closed LECS, but was treated successfully with endoscopic hemostasis for postoperative hemorrhage. The remaining patients treated with LECS did not have severe complications. During the follow-up period (median, 31 months), all patients were disease-free, with no tumor recurrence or metastases.

Conclusion: LECS is a safe surgical procedure for gastric intraluminal and intramural type GIST ≤ 50 mm in diameter, with good clinical outcomes.

Abstract Image

Abstract Image

腹腔镜内镜联合手术治疗胃肠道间质瘤的临床效果。
背景:腹腔镜内镜联合手术(LECS)是治疗胃肠道间质瘤(GIST)的一种公认的手术方式。在这篇报告中,我们描述了在我们的机构中LECS手术治疗胃间质瘤的临床结果。方法:2012年9月至2020年12月,我们对40例直径≤50 mm的胃腔内和胃壁内型GIST患者进行了LECS手术,包括经典LECS、倒置LECS、闭合式LECS以及结合非暴露技术(CLEAN-NET)的腹腔镜和内镜联合入路。回顾性分析患者背景、手术结果、术后发病率和死亡率以及肿瘤的临床病理特征。结果:病理结果显示多数患者肿瘤复发风险低或极低,有1例患者肿瘤复发风险高。术后住院时间中位数为7天。根据Clavien-Dindo (C-D)分类,只有1例患者在闭合LECS后出现严重的术后III级并发症,但经内镜止血治疗术后出血成功。其余接受LECS治疗的患者均未出现严重并发症。在随访期间(中位31个月),所有患者均无疾病,无肿瘤复发或转移。结论:对于直径≤50 mm的胃腔内和壁内型GIST, LECS是一种安全的手术方法,临床效果良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Fukushima Journal of Medical Science
Fukushima Journal of Medical Science MEDICINE, GENERAL & INTERNAL-
CiteScore
1.70
自引率
12.50%
发文量
24
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信